ID: ALA3618487

Max Phase: Preclinical

Molecular Formula: C31H53NO23

Molecular Weight: 807.75

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1NC1=C[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O

Standard InChI:  InChI=1S/C31H53NO23/c1-7-13(16(39)22(45)29(49-7)54-26-11(5-35)50-28(48)21(44)19(26)42)32-9-2-8(3-33)25(18(41)14(9)37)53-31-24(47)20(43)27(12(6-36)52-31)55-30-23(46)17(40)15(38)10(4-34)51-30/h2,7-8,10-48H,3-6H2,1H3/t7-,8-,10-,11-,12-,13-,14+,15-,16+,17+,18-,19-,20-,21-,22-,23-,24-,25-,26-,27-,28+,29-,30-,31-/m1/s1

Standard InChI Key:  CRGKQNDUHLRYGH-RQYVBDGISA-N

Associated Targets(Human)

Pancreatic alpha-amylase 74 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 807.75Molecular Weight (Monoisotopic): 807.3008AlogP: -10.54#Rotatable Bonds: 12
Polar Surface Area: 400.32Molecular Species: NEUTRALHBA: 24HBD: 17
#RO5 Violations: 3HBA (Lipinski): 24HBD (Lipinski): 17#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.19CX Basic pKa: 5.22CX LogP: -9.66CX LogD: -9.66
Aromatic Rings: 0Heavy Atoms: 55QED Weighted: 0.09Np Likeness Score: 1.32

References

1. Al-Asri J, Fazekas E, Lehoczki G, Perdih A, Görick C, Melzig MF, Gyémánt G, Wolber G, Mortier J..  (2015)  From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors.,  23  (20): [PMID:26395057] [10.1016/j.bmc.2015.09.007]

Source